BACKGROUND. Cerebral malaria is a severe complication of Plasmodium falciparum infection in children, with a mortality rate of 15 to 50 percent despite antimalarial therapy. METHODS. To determine whether combining iron chelation with quinine therapy speeds the recovery of consciousness, we conducted a randomized, double-blind, placebo-controlled trial of the iron chelator deferoxamine in 83 Zambian children with cerebral malaria. To be enrolled, patients had to be less than six years old, have P. falciparum parasitemia, have normal cerebrospinal fluid without evidence of bacterial infection, and be in a coma from which they could not be aroused. Deferoxamine (100 mg per kilogram of body weight per day, infused intravenously for 72 hours) or placebo was added to standard therapy with quinine and sulfadoxine-pyrimethamine. The time to the recovery of full consciousness, time to parasite clearance, and mortality were examined with Cox proportional-hazards regression analysis. RESULTS. The rate of recovery of full consciousness among the 42 patients given deferoxamine was 1.3 times that among the 41 given placebo (95 percent confidence interval, 0.7 to 2.3); the median time to recovery was 20.2 hours in the deferoxamine group and 43.1 hours in the placebo group (P = 0.38). Among 50 patients with deep coma, the rate of recovery of full consciousness was increased 2.2-fold with deferoxamine (95 percent confidence interval, 1.1 to 4.7), decreasing the median recovery time from 68.2 to 24.1 hours (P = 0.03). Among 69 patients for whom data on parasite clearance were available, the rate of clearance with deferoxamine was 2.0 times that with placebo (95 percent confidence interval, 1.2 to 3.6). Among all 83 patients, mortality was 17 percent in the deferoxamine group and 22 percent in the placebo group (P = 0.52). CONCLUSIONS. Iron chelation therapy may hasten the clearance of parasitemia and enhance recovery from deep coma in cerebral malaria.
Source Information
Case Western Reserve University School of Medicine, Cleveland, OH.
This article has been cited by other articles:
Casals-Pascual, C., Idro, R., Gicheru, N., Gwer, S., Kitsao, B., Gitau, E., Mwakesi, R., Roberts, D. J., Newton, C. R. J. C.
(2008). High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc. Natl. Acad. Sci. USA
105: 2634-2639
[Abstract][Full Text]
Pradines, B., Tall, A., Ramiandrasoa, F., Spiegel, A., Sokhna, C., Fusai, T., Mosnier, J., Daries, W., Trape, J. F., Kunesch, G., Parzy, D., Rogier, C.
(2006). In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum. J Antimicrob Chemother
57: 1093-1099
[Abstract][Full Text]
LADEMANN, M., GABELIN, P., LAFRENZ, M., WERNITZ, C., EHMKE, H., SCHMITZ, H., REISINGER, E. C.
(2005). ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING PLASMODIUM FALCIPARUM MALARIA CAUSED BY VARICELLA ZOSTER VIRUS REACTIVATION. Am J Trop Med Hyg
72: 478-480
[Abstract][Full Text]
Gasche, C, Lomer, M C E, Cavill, I, Weiss, G
(2004). Iron, anaemia, and inflammatory bowel diseases. Gut
53: 1190-1197
[Abstract][Full Text]
MUNG'ALA-ODERA, V., SNOW, R. W., NEWTON, C. R. J. C.
(2004). THE BURDEN OF THE NEUROCOGNITIVE IMPAIRMENT ASSOCIATED WITH PLASMODIUM FALCIPARUM MALARIA IN SUB-SAHARAN AFRICA. Am J Trop Med Hyg
71: 64-70
[Abstract][Full Text]
Rotheneder, A., Fritsche, G., Heinisch, L., Mollmann, U., Heggemann, S., Larcher, C., Weiss, G.
(2002). Effects of Synthetic Siderophores on Proliferation of Plasmodium falciparum in Infected Human Erythrocytes. Antimicrob. Agents Chemother.
46: 2010-2013
[Abstract][Full Text]
Pradines, B., Ramiandrasoa, F., Rolain, J. M., Rogier, C., Mosnier, J., Daries, W., Fusai, T., Kunesch, G., Le Bras, J., Parzy, D.
(2002). In Vitro Potentiation of Antibiotic Activities by a Catecholate Iron Chelator against Chloroquine-Resistant Plasmodium falciparum. Antimicrob. Agents Chemother.
46: 225-228
[Abstract][Full Text]
Oppenheimer, S. J.
(2001). Iron and Its Relation to Immunity and Infectious Disease. J. Nutr.
131: 616S-635
[Abstract][Full Text]
Newton, C. R J C, Hien, T. T., White, N.
(2000). NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Cerebral malaria. J. Neurol. Neurosurg. Psychiatry
69: 433-441
[Abstract][Full Text]
Jacobson, E. S., Goodner, A. P., Nyhus, K. J.
(1998). Ferrous Iron Uptake in Cryptococcus neoformans. Infect. Immun.
66: 4169-4175
[Abstract][Full Text]
Gachot, B., Doyon, F., Hill, C., Fruchter, O., Newmark, A., van Hensbroek, M. B., Greenwood, B., Kwiatkowski, D., Hien, T. T., Day, N. P.J., White, N. J.
(1996). Artemether in Severe Malaria. NEJM
335: 1922-1924
[Full Text]
Moore, T. A., Tomayko, J. F. Jr, Wierman, A. M., Rensimer, E. R., White, A. C. Jr
(1994). Imported Malaria in the 1990s: A Report of 59 Cases From Houston, Tex. Arch Fam Med
3: 130-136
[Abstract]
Herbert, V., Taylor, T. E., Molyneux, M. E., Thuma, P. E., Gordeuk, V., Brittenham, G.
(1993). Folate Deficiency to Protect against Malaria. NEJM
328: 1127-1128
[Full Text]
